Aster DM Healthcare, one of the leading integrated healthcare service providers in India, has announced its financial results for the quarter ended December 31, 2025.
Key highlights
Aster DM Healthcare for Q3 FY26:
- Revenue for Q3 FY26 grew 13% YoY to Rs 1,186 crore
- Operating EBITDA (ex-Kasaragod) grew 17% YoY to Rs 237 crore in Q3 FY26
- Operating EBITDA Margins (ex-Kasaragod) stood at 20.2% in Q3 FY26 Vs. 19.3% in Q3 FY25
- Normalised PAT1 (ex-Kasaragod) grew 22% YoY to Rs 98 crore In Q3 FY26
Aster + QCIL (Combined Proforma) Performance for Q3 FY26
- Revenue for Q3FY26 grew by 15% to Rs 2,366 crore
- Operating EBITDA grew by 22% to Rs 503 crore
- Operating EBITDA margin stood at 21%
Commenting on the performance for Q3 FY26, Azad Moopen, founder and chairman, Aster DM Healthcare, said, “As we move closer to the completion of merger between Aster and Quality Care India Limited, the proforma performance of the combined platform remains encouraging. On a proforma basis in Q3 FY26, revenues grew by 15% YoY to Rs. 2,366 crore and operating EBITDA incroreeased by 22% YoY to Rs. 503 crore. The combined performance remained largely consistent throughout the three quarters of FY26, supported by strong patient volumes and improving case mix.
Over the past year, the combined entity has added over 560 beds, taking the combined capacity to 10,620 beds acroreoss 28 cities, with a pipeline of more than 4,000 additional beds to support long-term growth. With continued focus on strengthening clinical talent, leadership depth, and execution excellence, we remain well positioned to deliver sustainable expansion and provide high-quality, accessible healthcare at scale.
We are also pleased with the progress made on the merger and are confident of shareholders’ approval pursuant to the NCLT order marking an important step in toward croreeating a scaled, integrated healthcare platform to become the top 3 hospital chains in India.”
On the Q3 FY26 performance of Aster DM Healthcare, Dr. Moopen said, “We have delivered a steady performance with revenues incroreeasing 13% YoY to Rs. 1,186 crore and excluding the impact of the newly commissioned Kasargod facility, operating EBITDA grew 17% year on year, with margins expanding to 20.2%, reflecting strong operating leverage and cost management.”
